These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8924222)

  • 21. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1.
    Acharya KR; Passalacqua EF; Jones EY; Harlos K; Stuart DI; Brehm RD; Tranter HS
    Nature; 1994 Jan; 367(6458):94-7. PubMed ID: 8107781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U; McLellan B; Kraus E; Huber BT
    Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC.
    Wang S; Li Y; Xiong H; Cao J
    Immunol Lett; 2008 Dec; 121(2):167-72. PubMed ID: 19028523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
    Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
    Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens.
    Torres BA; Griggs ND; Johnson HM
    Nature; 1993 Jul; 364(6433):152-4. PubMed ID: 8391645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
    von Bonin A; Ehrlich S; Malcherek G; Fleischer B
    Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The bacterial superantigen and superantigen-like proteins.
    Fraser JD; Proft T
    Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superantigen-like properties of an antibody bispecific for MHC class II molecules and the V beta domain of the T cell antigen receptor.
    Yagi J; Nakata M; Uchiyama T; Nishikawa M; Mizushima Y; Nishioka K; Ito K; Yagita H; Okumura K; Janeway CA
    J Immunol; 1994 Apr; 152(8):3833-41. PubMed ID: 8144952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The structural basis of T cell activation by superantigens.
    Li H; Llera A; Malchiodi EL; Mariuzza RA
    Annu Rev Immunol; 1999; 17():435-66. PubMed ID: 10358765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural dichotomy of staphylococcal enterotoxin C superantigens leading to MHC class II-independent activation of T lymphocytes.
    Lamphear JG; Bohach GA; Rich RR
    J Immunol; 1998 Mar; 160(5):2107-14. PubMed ID: 9498747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of T cells by superantigen in class II-negative mice.
    Avery AC; Markowitz JS; Grusby MJ; Glimcher LH; Cantor H
    J Immunol; 1994 Dec; 153(11):4853-61. PubMed ID: 7963549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
    Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
    Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superantigens as immunomodulators: recent structural insights.
    Papageorgiou AC; Acharya KR
    Structure; 1997 Aug; 5(8):991-6. PubMed ID: 9309216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional evaluation of HIV/SIV Nef as superantigen.
    Lapatschek MS; Dürr S; Sutter G; Wagner H; Miethke T
    Virology; 2001 Apr; 282(2):329-37. PubMed ID: 11289815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling of receptor mimics that inhibit superantigen pathogenesis.
    Möllhoff M; Zanden HB; Shiflett PR; Gupta G
    J Mol Recognit; 2005; 18(1):73-83. PubMed ID: 15459942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity.
    Vath GM; Earhart CA; Monie DD; Iandolo JJ; Schlievert PM; Ohlendorf DH
    Biochemistry; 1999 Aug; 38(32):10239-46. PubMed ID: 10441117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Structures of bacterial superantigen on the molecular basis and their activities to the immune system].
    Miyoshi-Akiyama T; Uchiyama T
    Tanpakushitsu Kakusan Koso; 2001 Mar; 46(4 Suppl):567-74. PubMed ID: 11268662
    [No Abstract]   [Full Text] [Related]  

  • 38. [Superantigens and antigen recognition of T lymphocytes].
    Gülmezoğlu E
    Mikrobiyol Bul; 1993 Apr; 27(2):164-70. PubMed ID: 8502189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen.
    Jardetzky TS; Brown JH; Gorga JC; Stern LJ; Urban RG; Chi YI; Stauffacher C; Strominger JL; Wiley DC
    Nature; 1994 Apr; 368(6473):711-8. PubMed ID: 8152483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porcine MHC classical class I genes are coordinately expressed in superantigen-activated mononuclear cells.
    Kametani Y; Ohshima S; Kita YF; Shimada S; Kamiguchi H; Shiina T; Inoko H; Kulski JK; Ando A
    Vet Immunol Immunopathol; 2012 Aug; 148(3-4):252-9. PubMed ID: 22640570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.